Persistent URL of this record https://hdl.handle.net/1887/109165
In Collections
This item can be found in the following collections:
Prospective Randomized Open-label Multicenter Phase I/II Dose Escalation Trial of Visilizumab (HuM291) in Severe Steroid-refractory Ulcerative Colitis
- All authors
- Baumgart, D.C.; Targan, S.R.; Dignass, A.U.; Mayer, L.; Assche, G. van; Hommes, D.W.; Hanauer, S.B.; Mahadevan, U.; Reinisch, W.; Plevy, S.E.; Salzberg, B.A.; Buchman, A.L.; Mechkov, G.M.; Krastev, Z.A.; Lowder, J.N.; Frankel, M.B.; Sandborn, W.J.
- Date
- 2010-04-30
- Journal
- Inflammatory Bowel Diseases
- Volume
- 16
- Issue
- 4
- Pages
- 620 - 629